Investor Relations

About the Company

CorTec is a limited liability company founded in 2010. The company is located in Freiburg, Germany. In August of 2018 CorTec has moved to own premises at Freiburg Fairground where 1,000 squaremeters of office space and 400 squaremeters of cleanroom and laboratory facilities which enable further growth.

Innovations in Technology and Therapy

CorTec provides different technologies which support recording and stimulating neural signals. Single components like electrodeshermetic packagingsoftware, or electronics, or complete system CorTec Brain Interchange enable the communication with the nervous system. CorTec, therefore, ist offering the most relevant components for the development of innovative personalized therapies for different neural diseases.

The core of CorTec’s technology is the closed-loop implant system Brain Interchange: The Brain Interchange technology is able to respond to the physiological state of the patient. It measures the brain signals of the patient, evaluates the data and autonomously adjusts stimulation to the current condition of the patient. This will allow a therapy that can be specifically adapted to the momentary needs of the individual patient.

Closed-loop systems have a promising future on the rapidly growing market of neuroptherapy. CorTec is in the process ot establishing itself as development partner in demand and will gradually seize this market as innovation leader.


In the fall of 2019, CorTec closed a further financing round, for which a new investor, Santo Venture Capital, the investment company of the Strüngmann family, was acquired. In addition to LBBW Venture Capital, several previously represented investors are participating in the financing round.

In spring 2016 CorTec has closed a series B financing. Mangold Invest could be attracted as a new investor whilst also the majority of the previous investors participated.

In addition to their investment, the company is funded by public subsidies for example from the German Federal Ministry of Education and Research (Bundesministerium für Bildung und Forschung, BMBF) and the European Union. CorTec is involved in several projects with partners from industry and research that contribute to the further development of CorTec’s technology.


In addition to significant public funding CorTec has raised 4 rounds of financing. The following page introduces you to our current investors.


Do you have any questions regarding our company or our technology?
We appreciate your feedback.


Our products provide solutions to your individual challenge.

Take a closer look in the ‘Solutions’ section and find out about our products for pre-clinical research, industry and clinial use and their specifications.

CorTec Stories

You would like to get to know us even better?
Take a look at our Stories section and discover CorTec through Technology, User Stories and more.